DE3582439D1
(de)
*
|
1984-01-28 |
1991-05-16 |
Roshdy Ismail |
Mittel zur behandlung von herzerkrankungen.
|
US5656620A
(en)
*
|
1984-01-28 |
1997-08-12 |
Ismail; Roshdy |
Method for treating pain
|
US4844984A
(en)
*
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US5000957A
(en)
*
|
1984-03-19 |
1991-03-19 |
Alza Corporation |
Dispenser comprising hydrophilic osmopolymer
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
US4716496A
(en)
*
|
1986-05-09 |
1987-12-29 |
Eaton Corporation |
Panel-mounted control station housing
|
US4904477A
(en)
*
|
1987-07-08 |
1990-02-27 |
American Home Products Corporation |
Spray dried ibuprofen compositions
|
GB8717168D0
(en)
*
|
1987-07-21 |
1987-08-26 |
Roussel Lab Ltd |
Controlled-release device
|
US4898734A
(en)
*
|
1988-02-29 |
1990-02-06 |
Massachusetts Institute Of Technology |
Polymer composite for controlled release or membrane formation
|
US4966769A
(en)
*
|
1988-06-02 |
1990-10-30 |
Alza Corporation |
Method for delivering dosage form for diltiazem
|
JP2835051B2
(ja)
*
|
1988-07-06 |
1998-12-14 |
オリンパス光学工業株式会社 |
医療用カプセル
|
US5612059A
(en)
*
|
1988-08-30 |
1997-03-18 |
Pfizer Inc. |
Use of asymmetric membranes in delivery devices
|
IL91398A
(en)
*
|
1988-08-30 |
1994-05-30 |
Pfizer |
A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Hydrogel-operated release devices
|
US5342624A
(en)
*
|
1989-02-16 |
1994-08-30 |
British Technology Group Ltd. |
Dispensing device
|
GB8903564D0
(en)
*
|
1989-02-16 |
1989-04-05 |
Rashid Abdul |
Drug dispensing device
|
US5372776A
(en)
*
|
1989-04-07 |
1994-12-13 |
Alza Corporation |
Density element and method of manufacture thereof to achieve a particular transverse rupture strength
|
US5206024A
(en)
*
|
1989-04-07 |
1993-04-27 |
Alza Corporation |
Density element for ruminal delivery device
|
US5417976A
(en)
*
|
1989-04-07 |
1995-05-23 |
Alza |
Density element and method of manufacture thereof
|
US5100392A
(en)
*
|
1989-12-08 |
1992-03-31 |
Biosynthesis, Inc. |
Implantable device for administration of drugs or other liquid solutions
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5156623A
(en)
*
|
1990-04-16 |
1992-10-20 |
Olympus Optical Co., Ltd. |
Sustained release material and method of manufacturing the same
|
JPH0794379B2
(ja)
*
|
1990-08-07 |
1995-10-11 |
ファイザー・インコーポレーテッド |
放出製剤における界面重合膜の使用方法
|
US5713888A
(en)
*
|
1990-10-31 |
1998-02-03 |
Baxter International, Inc. |
Tissue implant systems
|
KR0169495B1
(ko)
*
|
1990-10-31 |
1999-01-15 |
쥐. 마샬 애비 |
폐쇄 혈관신생 이식 물질
|
US5733336A
(en)
*
|
1990-10-31 |
1998-03-31 |
Baxter International, Inc. |
Ported tissue implant systems and methods of using same
|
US5314696A
(en)
*
|
1991-06-27 |
1994-05-24 |
Paulos Manley A |
Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
|
US5302397A
(en)
*
|
1991-11-19 |
1994-04-12 |
Amsden Brian G |
Polymer-based drug delivery system
|
ES2170069T3
(es)
*
|
1992-06-22 |
2002-08-01 |
Bone Care Int Inc |
1-alfa-hidroxiprevitamina d para administracion oral.
|
US5795882A
(en)
*
|
1992-06-22 |
1998-08-18 |
Bone Care International, Inc. |
Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
|
US5609885A
(en)
*
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
US5681811A
(en)
*
|
1993-05-10 |
1997-10-28 |
Protein Delivery, Inc. |
Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
|
US6191105B1
(en)
|
1993-05-10 |
2001-02-20 |
Protein Delivery, Inc. |
Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
|
WO1994028878A1
(en)
*
|
1993-06-14 |
1994-12-22 |
Emisphere Technologies, Inc. |
Proteinoid carriers
|
US5651976A
(en)
*
|
1993-06-17 |
1997-07-29 |
The United States Of America As Represented By The Secretary Of The Navy |
Controlled release of active agents using inorganic tubules
|
CA2148354A1
(en)
*
|
1993-09-24 |
1995-03-30 |
Laura A. Martinson |
Methods for enhancing vascularization of implant devices
|
US6156305A
(en)
*
|
1994-07-08 |
2000-12-05 |
Baxter International Inc. |
Implanted tumor cells for the prevention and treatment of cancer
|
US5607696A
(en)
*
|
1995-02-10 |
1997-03-04 |
Alza Corporation |
Osmotic membrane and delivery device
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
US6703381B1
(en)
*
|
1998-08-14 |
2004-03-09 |
Nobex Corporation |
Methods for delivery therapeutic compounds across the blood-brain barrier
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
US7169889B1
(en)
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US7713932B2
(en)
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6713452B2
(en)
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7196059B2
(en)
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US6913903B2
(en)
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
WO2003105768A2
(en)
*
|
2002-06-13 |
2003-12-24 |
Nobex Corporation |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
ES2695401T3
(es)
*
|
2003-02-12 |
2019-01-04 |
Syncera Inc |
Composiciones de aleación de polímeros de óxido de alquileno aleatorios y no aleatorios
|
EP2626368B1
(en)
|
2004-07-19 |
2016-12-21 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
EP1945185B1
(en)
*
|
2005-10-12 |
2016-02-03 |
Proventiv Therapeutics, LLC |
Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
|
US8426391B2
(en)
|
2006-02-03 |
2013-04-23 |
Proventiv Therapeutics, Llc |
Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
|
SI2679228T1
(en)
*
|
2006-06-21 |
2018-06-29 |
Opko Ireland Global Holdings, Ltd. |
THERAPY WITH THE USE OF VITAMIN D ADDITIONAL FIBER AND HORMON RESISTANCE OF VITAMIN D
|
EP2148685A4
(en)
*
|
2007-04-25 |
2010-07-28 |
Cytochroma Inc |
METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
|
DK3342405T3
(da)
|
2007-04-25 |
2019-11-11 |
Opko Ireland Global Holdings Ltd |
Kontrolleret frigivelse af 25-hydroxyvitamin d
|
WO2008134523A1
(en)
|
2007-04-25 |
2008-11-06 |
Proventiv Therapeutics, Llc |
Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
|
ES2403107T3
(es)
*
|
2007-04-25 |
2013-05-14 |
Cytochroma Inc. |
Método de tratamiento de insuficiencia y deficiencia de vitamina D
|
US20130079749A1
(en)
*
|
2007-08-29 |
2013-03-28 |
Advanced Bionics, Llc |
Modular Drug Delivery System for Minimizing Trauma During and After Insertion of a Cochlear Lead
|
BRPI0818004B8
(pt)
|
2007-10-16 |
2021-05-25 |
Biocon Ltd |
composição farmacêutica sólida administrável por via oral e o processo da mesma.
|
KR101852042B1
(ko)
|
2008-04-02 |
2018-04-25 |
사이토크로마 인코포레이티드 |
비타민 d 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
|
EP2459116B1
(en)
|
2009-07-31 |
2019-10-09 |
Boehringer Ingelheim Animal Health USA Inc. |
Sustained release capsules
|
EP3636280A1
(en)
|
2010-03-29 |
2020-04-15 |
Opko Ireland Global Holdings, Ltd. |
Methods and compositions for reducing parathyroid levels
|
KR101847947B1
(ko)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
안정화되고 변형된 비타민 d 방출 제형
|
SG10201911274TA
(en)
|
2014-08-07 |
2020-02-27 |
Opko Ireland Global Holdings Ltd |
Adjunctive therapy with 25-hydroxyvitamin d
|
SG10201913863TA
(en)
|
2016-03-28 |
2020-03-30 |
Opko Ireland Global Holdings Limited |
Methods of vitamin d treatment
|